Navigating A 60% Potential Upside In The Medical Devices Sector
In the rapidly evolving medical devices sector, Glaukos Corporation (NYSE: GKOS) stands out as a formidable player specializing in ophthalmic pharmaceuticals and medical technologies. With a market capitalization of $4.28 billion, Glaukos is making significant strides in developing innovative therapies for glaucoma, corneal disorders, and retinal diseases. Despite a modest price change of -0.01% at its current price of $74.67, the stock presents an intriguing potential upside of 60.04%, based on the average analyst target price of $119.50.
### Company Overview and Market Position ###
Founded in 1998 and headquartered in Aliso Viejo, California, Glaukos has made a name for itself with groundbreaking products such as the iStent and…
